Skip to main content

Table 1 Baseline characteristics of patients with CA-UTI and other-cUTI (n = 807 episodes)

From: Clinical outcomes of hospitalised patients with catheter-associated urinary tract infection in countries with a high rate of multidrug-resistance: the COMBACTE-MAGNET RESCUING study

FactorsCA-UTI
(n = 341)
Other cUTI
(n = 466)
p-value
Male gender, n (%)197 (57.8%)222 (47.6)0.006
Age, median (IQR)71 (60–82)68 (56.2–79)0.009
Diabetes mellitus, n (%)109 (32.2)113 (24.2)0.019
Haematological malignancy, n (%)8 (2.3)10 (2.1)0.84
Solid tumour, n (%)42 (12.3)63 (13.8)0.74
Liver disease, n (%)16 (4.7)26 (5.58)0.68
Urgent admission, n (%)285 (83.6)394 (84.5)0.78
Admission reason:  < 0.001
 Other reasons213 (62.5)120 (25.8) 
 cUTI128 (37.5)346 (74.2) 
Admission from medical care facility, n (%)88 (25.8)90 (13.5)< 0.001
Charlson score, median (IQR)3 (1–5)2 (0–4)< 0.001
Organ transplantation, n (%)10 (2.9)50 (10.7)< 0.001
Immunosuppressive therapy, n (%)19 (5.6)63 (13.5)< 0.001
Steroid therapy, n (%)22 (6.5)32 (6.87)0.92
Functional capacity: Bedridden, n (%)91 (26.7)55 (11.8)< 0.001
Chronic renal impairment, n (%)72 (21.2)141 (30.8)0.005
UTI within 1 year, n (%)79 (23.2)143 (30.8)0.021
Antibiotic within 30 days, n (%)67 (19.7)104 (22.5)0.39
Acquisition of cUTI at a medical care facility, n (%)254 (74.5)160 (34.3)< 0.001
Urinary retention, n (%)70 (20.5)112 (24)0.27
Neurogenic bladder32 (9.4)12 (2.58)< 0.001
Obstructive uropathy43 (12.6)166 (35.8)< 0.001
Severity of infection: Severe sepsis/septic shock, n (%)49 (15.4)70 (15.9)0.92
  1. CA-UTI catheter-associated urinary tract infection (CA-UTI), complicated urinary tract infection due to other sources (other-cUTI). IQR Interquartile range, cUTI complicated urinary tract infection, and UTI urinary tract infection